Use of Myeloma Patient Outcome Scale (MyPOS) to gauge the effectiveness of palliative management in patients with multiple myeloma: Experience from a large tertiary academic center in India

被引：0
|
作者：
Kapoor, Astha Koolwal
Mishra, Seema
Bhatnagar, Sushma
Kumar, Lalit
Garg, Rakesh
Gupta, Nishkarsh
Kumar, Vinod
JeeBharti, Sachidanand
机构：
[1] Nuvance Hlth, Arlington, NY USA
[2] All India Inst Med Sci, New Delhi, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24137
引用
收藏
页数：1
相关论文
共 12 条
  • [1] Development and validation of the Myeloma Patient Outcome Scale (MyPOS): A quality of life questionnaire for use in the clinical care of people with multiple myeloma
    Osborne, Thomas
    Ramsenthaler, Christina
    De Wolf-Linder, Susanne
    Pannell, Caty
    Siegert, Richard J.
    Edmonds, Polly
    Schey, Steve
    Higginson, Irene J.
    [J]. QUALITY OF LIFE RESEARCH, 2014, 23 : 39 - 39
  • [2] Development and Validation of the Myeloma Patient Outcome Scale (MyPOS): A Questionnaire to Assess Physical, Psychological; and Health Care Palliative Care Needs for Use in the Clinical Care of People with Multiple Myeloma
    Osborne, Thomas R.
    Ramsenthaler, Christina
    De Wolf-Linder, Susanne
    Pannell, Caty
    Siegert, Richard J.
    Edmonds, Polly M.
    Schey, Steve A.
    Higginson, Irene J.
    [J]. JOURNAL OF PALLIATIVE CARE, 2014, 30 (03) : 234 - 234
  • [3] Bortezomib in newly diagnosed patients with multiple myeloma: A retrospective analysis from a tertiary care center in India
    Pragnya, C.
    Linga, V. G.
    Thota, N. K.
    Gundeti, S.
    Digumarti, R.
    [J]. INDIAN JOURNAL OF CANCER, 2015, 52 (04) : 537 - 540
  • [4] Cytogenetic Alterations and Correlation with Age and Gender in Patients of Multiple Myeloma: A Study from a Tertiary Care Center in Eastern India
    Jha, Karuna
    Saha, Sandeep
    Bhattacharyya, Maitreyee
    [J]. SOUTH ASIAN JOURNAL OF CANCER, 2024, 13 (02) : 126 - 131
  • [5] Minimal Residual Disease Analysis in Multiple Myeloma Patients By 6-Color Flow Cytometry: An Experience from Tertiary Care Center of North India
    Sharma, Praveen
    Sachdeva, Man Updesh Singh
    Varma, Neelam
    Bose, Parveen
    Malhotra, Pankaj
    [J]. BLOOD, 2015, 126 (23)
  • [6] Improved Treatment Outcome of Transplant Ineligible Multiple Myeloma in the Era of Novel Agents: Experience from Tertiary Care Centre in North India
    Nityanand, Soniya
    Gupta, Anshul
    Yadav, Sanjeev
    Kumar, Pradeep
    Garg, Akanksha
    Gupta, Ruchi
    Rahman, Khaliqur
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E234 - E234
  • [7] Use of ceftriaxone in stroke patients, a predictor of good outcome in stroke patients: experience from a tertiary care center in North India
    Pathak, A.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [8] Cost effective outcome of generic medicines used in CyBorD protocol induction and generic Melphalan Autologous transplant conditioning: Experience in 25 patients of multiple myeloma from single center in India
    Apte, S.
    Swamy, M.
    Joshi, A.
    Subramanyan, K.
    Balar, H.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S463 - S464
  • [9] Use of Denosumab after Zoledronic Acid in Patients with Multiple Myeloma: Real-World Experience from 2015 to 2019 at Yale Cancer Center
    Dosani, Talib
    Poteraj, Anna
    Parker, Terri L.
    Bar, Noffar
    Browning, Sabrina L.
    Gorshein, Elan
    Anderson, Tara
    Insogna, Karl
    Neparidze, Natalia
    [J]. BLOOD, 2021, 138
  • [10] Treatment outcome of thalidomide based regimens in newly diagnosed and relapsed/refractory non-transplant multiple myeloma patients: a single center experience from Thailand
    Niparuck, Pimjai
    Sorakhunpipitkul, Ladda
    Atichartakarn, Vichai
    Chuncharunee, Suporn
    Ungkanont, Artit
    Aungchaisuksiri, Pantep
    Puavilai, Teeraya
    Jootar, Saengsuree
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2010, 3
12